Clinical Trial Update: [KJ-INT-002] BE Study [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of KJ-INT-002 for gastritis; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis

Drugs mentioned

• KJ-INT-002

Snippet

Sponsor: Kukje Pharma | Conditions: Gastritis | Phase 1 | Status: UNKNOWN